Vestal Point Capital, LP Amicus Therapeutics, Inc. Transaction History
Vestal Point Capital, LP
- $1.9 Trillion
- Q2 2025
A detailed history of Vestal Point Capital, LP transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Vestal Point Capital, LP holds 11,900,000 shares of FOLD stock, worth $83.1 Million. This represents 3.59% of its overall portfolio holdings.
Number of Shares
11,900,000
Previous 4,275,000
178.36%
Holding current value
$83.1 Million
Previous $34.9 Billion
95.47%
% of portfolio
3.59%
Previous 2.49%
Shares
3 transactions
Others Institutions Holding FOLD
# of Institutions
299Shares Held
332MCall Options Held
396KPut Options Held
246K-
Vanguard Group Inc Valley Forge, PA29.4MShares$205 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA29.1MShares$203 Million0.03% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$170 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY18MShares$126 Million1.88% of portfolio
-
William Blair Investment Management, LLC Chicago, IL14.6MShares$102 Million0.24% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $1.96B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...